Literature DB >> 29720054

Newly Proposed Sepsis-Induced Coagulopathy Precedes International Society on Thrombosis and Haemostasis Overt-Disseminated Intravascular Coagulation and Predicts High Mortality.

Toshiaki Iba1, Makoto Arakawa1, Marcello Di Nisio2, Satoshi Gando3, Hideaki Anan4, Koichi Sato5, Yutaka Ueki6, Jerrold H Levy7, Jecko Thachil8.   

Abstract

BACKGROUND: Disseminated intravascular coagulation (DIC) has been recognized as an urgent and critical condition in patients with sepsis. Therefore, unfamiliar and time-consuming tests or a complex scoring system are not suitable for diagnosis. Sepsis-induced coagulopathy (SIC), a newly proposed category delineated by a few global coagulation tests, has been established as an early warning sign for DIC. The purpose of this study was to elucidate the characteristics of SIC, especially in relation to the score of the International Society on Thrombosis and Haemostasis (ISTH) for overt DIC.
METHOD: A data set for 332 patients with sepsis who were suspected to have DIC, antithrombin activity <70%, and treated with antithrombin substitution was utilized to examine the relationship between SIC and overt DIC. The performance of SIC calculated at baseline (ie, before treatment) as well as on days 2, 4, or 7 was analyzed in terms of its ability to predict 28-day mortality and overt DIC.
RESULTS: At baseline, 149 (98.7%) of 151 patients with overt DIC according to the ISTH definition were diagnosed as having SIC. Of the 49, 46 (93.9%) patients who developed overt DIC between days 2 and 4 had received a prior diagnosis of SIC. The sensitivity of baseline SIC for the prediction of death was significantly higher than that of overt DIC (86.8% vs 64.5%, P < .001). The sensitivity of SIC on days 2, 4, and 7 was significantly higher than those of overt DIC (96.1%, 92.3%, and 84.4% vs 67.1%, 57.7%, and 50.0%, P < .001, .001, and .001, respectively), although the specificity of SIC was lower at all time points.

Entities:  

Keywords:  diagnostic criteria; disseminated intravascular coagulation; platelet count; prothrombin time; sepsis

Mesh:

Substances:

Year:  2018        PMID: 29720054     DOI: 10.1177/0885066618773679

Source DB:  PubMed          Journal:  J Intensive Care Med        ISSN: 0885-0666            Impact factor:   3.510


  13 in total

1.  The prognostic role of ThromboDynamic Index in patients with severe sepsis.

Authors:  Annalisa Boscolo; Luca Spiezia; Elena Campello; Elisabetta Maria Consolaro; Carlo Ori; Paolo Simioni
Journal:  Intern Emerg Med       Date:  2019-07-02       Impact factor: 3.397

2.  Coagulopathy of Patients with COVID-19 is Associated with Infectious and Inflammatory Markers.

Authors:  Xin Long; Zhanguo Zhang; Wenbin Zou; Jianmin Ling; Donghui Li; Liang Jing; Shanshan Yu; Xiaojing Zou; Yi Bian; Wenjuan Wu; Shusheng Li; Minghao Fang
Journal:  Risk Manag Healthc Policy       Date:  2020-10-07

Review 3.  Sepsis-Pathophysiology and Therapeutic Concepts.

Authors:  Dominik Jarczak; Stefan Kluge; Axel Nierhaus
Journal:  Front Med (Lausanne)       Date:  2021-05-14

4.  Is there a rationale for heparin use among severe COVID-19 patients?

Authors:  Felicio Savioli
Journal:  Einstein (Sao Paulo)       Date:  2020-05-29

5.  Activated Clotting Time as a Marker of Inflammation in Hospitalized Patients.

Authors:  Christos Papageorgiou; Andreas Synetos; Konstantinos Tampakis; Hector Anninos; Christos Kontogiannis; Alkistis Kapelouzou; Ioannis Kanakakis; Dimitrios Tousoulis; Ioannis Paraskevaidis; Konstantinos Toutouzas
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

6.  A Machine-Learning Approach for Dynamic Prediction of Sepsis-Induced Coagulopathy in Critically Ill Patients With Sepsis.

Authors:  Qin-Yu Zhao; Le-Ping Liu; Jing-Chao Luo; Yan-Wei Luo; Huan Wang; Yi-Jie Zhang; Rong Gui; Guo-Wei Tu; Zhe Luo
Journal:  Front Med (Lausanne)       Date:  2021-01-21

7.  [Progress in quantitative diagnosis of sepsis-induced disseminated intravascular coagulation].

Authors:  L L Luo; H Mei; Y Hu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-05-14

Review 8.  Recent advances in the research and management of sepsis-associated DIC.

Authors:  Toshiaki Iba; Jean Marie Connors; Isao Nagaoka; Jerrold H Levy
Journal:  Int J Hematol       Date:  2021-01-02       Impact factor: 2.490

Review 9.  A 21st Century Evil: Immunopathology and New Therapies of COVID-19.

Authors:  Taylon Felipe Silva; Fernanda Tomiotto-Pellissier; Raquel Arruda Sanfelice; Manoela Daiele Gonçalves; Bruna Taciane da Silva Bortoleti; Mariana Barbosa Detoni; Ana Carolina Jacob Rodrigues; Amanda Cristina Machado Carloto; Virgínia Márcia Concato; Elaine da Silva Siqueira; Idessania Nazareth Costa; Wander Rogério Pavanelli; Ivete Conchon-Costa; Milena Menegazzo Miranda-Sapla
Journal:  Front Immunol       Date:  2020-10-27       Impact factor: 7.561

10.  The Value of Thromboelastography in the Diagnosis of Sepsis-Induced Coagulopathy.

Authors:  Cuizhu Luo; Hongbin Hu; Jian Gong; Yun Zhou; Zhongqing Chen; Shumin Cai
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.